Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 57, 1194-1198, March 15, 1997]
© 1997 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanford, J. L.
Right arrow Articles by Ostrander, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanford, J. L.
Right arrow Articles by Ostrander, E. A.

Polymorphic Repeats in the Androgen Receptor Gene: Molecular Markers of Prostate Cancer Risk1

Janet L. Stanford2, Jeanette J. Just3, Mark Gibbs, Kristine G. Wicklund, Cassandra L. Neal, Brent A. Blumenstein and Elaine A. Ostrander4

Divisions of Public Health Sciences [J. L. S., K. G. W., B. A. B.] and Clinical Research [J. J. J., C. L. N., M. G., E. A. O.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98104

We analyzed the polymorphic (CAG)n and (GGN)n regions within the androgen receptor gene from participants in a population-based case-control study of prostate cancer in middle-aged (40–64 years) Caucasian men. The associations between repeat lengths and risk of prostate cancer and the effects of confounding and modifying factors, such as age, family history of prostate cancer, and body mass index, were evaluated. DNA was available for 301 cases and 277 controls. The overall age-adjusted relative odds of prostate cancer associated with the number of (CAG) repeats as a continuous variable was 0.97 [95% confidence interval (CI), 0.92–1.03], suggesting a 3% decrease in risk of prostate cancer for each additional (CAG) repeat. Further analyses identified several subgroups at increased risk. These were men with less than the median number of CAG repeats (<22) that were younger [<60 years; relative odds (RO), 1.47; 95% CI, 0.96–2.25], had an affected first-degree relative (RO, 1.59; 95% CI, 0.62–4.14), or were relatively thin (Quetelet index < 24.4; RO, 2.21; 95% CI, 1.07–4.69). Although only the latter result was statistically significant, these results are provocative and support the hypothesis that (CAG)n array length is a predictor of risk for prostate cancer. Similar analyses of (GGN)n showed that with the exception of men with a family history of prostate cancer and those in the highest quartile of body mass index, men with ≤16 repeats had higher risk estimates than did men with >16 repeats. Overall, those men who had ≤16 repeats had a significant elevation in risk (RO, 1.60; 95% CI, 1.07–2.41). When both repeat lengths were considered jointly, the subgroup with two short repeats (CAG, <22; GGN, ≤16) had a 2-fold elevation in odds (RO, 2.05; 95% CI, 1.09–3.84) relative to those with two long repeats (CAG, ≥22; GGN, >16). These data suggest that determination of both androgen receptor repeats within germ-line DNA may be useful in assessing an individual's risk of developing prostate cancer.

1 This work was supported in part by National Cancer Institute Grant R01 CA56678 (to J. L. S.) and contract N01-CN-05230, with additional support from the Fred Hutchinson Cancer Research Center; an award from the CaP CURE Foundation (to E. A. O.); and American Cancer Society Junior Faculty Award JFRA-558 (to E. A. O.).

2 Current address: Division of Public Health Sciences, University of Utah, 546 Chipeta Way, Suite 2100, Salt Lake City, UT 84108.

3 Current address: Millennium Pharmaceuticals, Inc., 640 Memorial Drive, 5th floor, Cambridge, MA 02139.

4 To whom requests for reprints should be addressed, at Clinical Research Division, Fred Hutchinson Cancer Research Center, 1124 Columbia Street M-318, Seattle, WA 98104. Phone: (206) 667-6979; Fax: (206) 667-6124.

Received 10/ 3/96. Accepted 1/15/97.




This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
M. L. Cutress, H. C. Whitaker, I. G. Mills, M. Stewart, and D. E. Neal
Structural basis for the nuclear import of the human androgen receptor
J. Cell Sci., April 1, 2008; 121(7): 957 - 968.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. A. Albertelli, O. A. O'Mahony, M. Brogley, J. Tosoian, M. Steinkamp, S. Daignault, K. Wojno, and D. M. Robins
Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice
Hum. Mol. Genet., January 1, 2008; 17(1): 98 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Lindstrom, F. Wiklund, H.-O. Adami, K. A. Balter, J. Adolfsson, and H. Gronberg
Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5-{alpha}-Reductase Type 2 Is Important for Prostate Cancer Development.
Cancer Res., November 15, 2006; 66(22): 11077 - 11083.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
S. Rajender, V. Rajani, N. J. Gupta, B. Chakravarty, L. Singh, and K. Thangaraj
No Association of Androgen Receptor GGN Repeat Length Polymorphism With Infertility in Indian Men
J Androl, November 1, 2006; 27(6): 785 - 789.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda, S. Narita, M. Shimbo, T. Kamoto, K. Mitsumori, T. Ichikawa, et al.
Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer
J. Clin. Oncol., May 1, 2006; 24(13): 1982 - 1989.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A Garolla, A Ferlin, C Vinanzi, A Roverato, G Sotti, W Artibani, and C Foresta
Molecular analysis of the androgen receptor gene in testicular cancer
Endocr. Relat. Cancer, September 1, 2005; 12(3): 645 - 655.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary
Molecular pathology of prostate cancer
J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. A. Platz, M. F. Leitzmann, N. Rifai, P. W. Kantoff, Y.-C. Chen, M. J. Stampfer, W. C. Willett, and E. Giovannucci
Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1262 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. T. E. Lim, M. Mansukhani, and I. B. Weinstein
Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells
PNAS, April 5, 2005; 102(14): 5156 - 5161.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Ferlin, A. Garolla, A. Bettella, L. Bartoloni, C. Vinanzi, A. Roverato, and C. Foresta
Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism
Eur. J. Endocrinol., March 1, 2005; 152(3): 419 - 425.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. K. Dunn, D. L. Wickerham, and L. G. Ford
Prevention of Hormone-Related Cancers: Breast Cancer
J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. P. Zeegers, L. A.L.M. Kiemeney, A. M. Nieder, and H. Ostrer
How Strong Is the Association Between CAG and GGN Repeat Length Polymorphisms in the Androgen Receptor Gene and Prostate Cancer Risk?
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1765 - 1771.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. Foley, D. Hollywood, and M. Lawler
Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease
Endocr. Relat. Cancer, September 1, 2004; 11(3): 477 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al.
Structural and functional consequences of glutamine tract variation in the androgen receptor
Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. Ferlin, L. Bartoloni, G. Rizzo, A. Roverato, A. Garolla, and C. Foresta
Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility
Mol. Hum. Reprod., June 1, 2004; 10(6): 417 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Milatiner, D. Halle, M. Huerta, E. J. Margalioth, Y. Cohen, A. Ben-Chetrit, M. Gal, T. Mimoni, and T. Eldar-Geva
Associations between androgen receptor CAG repeat length and sperm morphology
Hum. Reprod., June 1, 2004; 19(6): 1426 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Wang, T. S. Udayakumar, T. S. Vasaitis, A. M. Brodie, and J. D. Fondell
Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells
J. Biol. Chem., April 23, 2004; 279(17): 17319 - 17328.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. A. Heinlein and C. Chang
Androgen Receptor in Prostate Cancer
Endocr. Rev., April 1, 2004; 25(2): 276 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. E. BREDESEN, P. MEHLEN, and S. RABIZADEH
Apoptosis and Dependence Receptors: A Molecular Basis for Cellular Addiction
Physiol Rev, April 1, 2004; 84(2): 411 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. O. Lillie, L. Bernstein, S. A. Ingles, W. J. Gauderman, G. E. Rivas, V. Gagalang, T. Krontiris, and G. Ursin
Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy
Cancer Res., February 15, 2004; 64(4): 1237 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
R. O. Roberts, E. J. Bergstralh, J. M. Cunningham, S. J. Hebbring, S. N. Thibodeau, M. M. Lieber, and S. J. Jacobsen
Androgen Receptor Gene Polymorphisms and Increased Risk of Urologic Measures of Benign Prostatic Hyperplasia
Am. J. Epidemiol., February 1, 2004; 159(3): 269 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
P. Mehlen and D. E. Bredesen
Meeting Report: Cellular Dependence--Old Concept, New Mechanisms
Sci. Signal., December 16, 2003; 2003 (213): pe55 - pe55.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Liede, W. Zhang, M. L. D. L. Matsuda, A. Tan, and S. A. Narod
Androgen Receptor Gene Polymorphism and Breast Cancer Susceptibility in the Philippines
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 848 - 852.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. G. Nelson, A. M. De Marzo, and W. B. Isaacs
Prostate Cancer
N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Marchesani, A. Hakkarainen, T.-P. Tuomainen, J. Kaikkonen, E. Pukkala, P. Uimari, E. Seppala, M. Matikainen, O.-P. Kallioniemi, J. Schleutker, et al.
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
J Natl Cancer Inst, June 4, 2003; 95(11): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
D. J. Lamb, E. Puxeddu, N. Malik, D. L. Stenoien, R. Nigam, G. Y. Saleh, M. Mancini, N. L. Weigel, and M. Marcelli
Molecular Analysis of the Androgen Receptor in Ten Prostate Cancer Specimens Obtained Before and After Androgen Ablation
J Androl, March 1, 2003; 24(2): 215 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. M. Suter, K. E. Malone, J. R. Daling, D. R. Doody, and E. A. Ostrander
Androgen Receptor (CAG)n and (GGC)n Polymorphisms and Breast Cancer Risk in a Population-Based Case-Control Study of Young Women
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 127 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. R. Rebbeck
Inherited Genotype and Prostate Cancer Outcomes
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 945 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci
Is the Androgen Receptor CAG Repeat Length Significant for Prostate Cancer? : Commentary re: C. Chen et al., Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer. Cancer Epidemiol. Biomark. Prev., 11: 1033-1040, 2002
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 985 - 986.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Chen, N. Lamharzi, N. S. Weiss, R. Etzioni, D. A. Dightman, M. Barnett, D. DiTommaso, and G. Goodman
Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1033 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Gsur, M. Preyer, G. Haidinger, T. Zidek, S. Madersbacher, G. Schatzl, M. Marberger, C. Vutuc, and M. Micksche
Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk
Carcinogenesis, October 1, 2002; 23(10): 1647 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. G. Giles, G. Severi, R. Sinclair, D. R. English, M. R. E. McCredie, W. Johnson, P. Boyle, and J. L. Hopper
Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 549 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
L. A. COHEN
Nutrition and Prostate Cancer: A Review
Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 148 - 155.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. L. Giwercman, A. Nordenskjold, E. M. Ritzen, K. O. Nilsson, S.-A. Ivarsson, U. Grandell, and A. Wedell
An Androgen Receptor Gene Mutation (E653K) in a Family with Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency as well as in Partial Androgen Insensitivity
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2623 - 2628.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
K. A. Nelson and J. S. Witte
Androgen Receptor CAG Repeats and Prostate Cancer
Am. J. Epidemiol., May 15, 2002; 155(10): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. W. Hsing, A. P. Chokkalingam, Y.-T. Gao, G. Wu, X. Wang, J. Deng, J. Cheng, I. A. Sesterhenn, F. K. Mostofi, T. Chiang, et al.
Polymorphic CAG/CAA Repeat Length in the AIB1/SRC-3 Gene and Prostate Cancer Risk: A Population-based Case-Control Study
Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 337 - 341.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Sasaki, R. A. Betensky, J. G. Cairncross, and D. N. Louis
DMBT1 Polymorphisms: Relationship to Malignant Glioma Tumorigenesis
Cancer Res., March 1, 2002; 62(6): 1790 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. M. Matsumoto
Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99.
[Full Text]

Home page
 Cancer Res.Home page
C. A. Haiman, M. Brown, S. E. Hankinson, D. Spiegelman, G. A. Colditz, W. C. Willett, P. W. Kantoff, and D. J. Hunter
The Androgen Receptor CAG Repeat Polymorphism and Risk of Breast Cancer in the Nurses' Health Study
Cancer Res., February 1, 2002; 62(4): 1045 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. Mifsud, A. T. Choon, D. Fang, and E.L. Yong
Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men
Mol. Hum. Reprod., November 1, 2001; 7(11): 1007 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Modugno, J. L. Weissfeld, D. L. Trump, J. M. Zmuda, P. Shea, J. A. Cauley, and R. E. Ferrell
Allelic Variants of Aromatase and the Androgen and Estrogen Receptors: Toward a Multigenic Model of Prostate Cancer Risk
Clin. Cancer Res., October 1, 2001; 7(10): 3092 - 3096.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium
PNAS, September 4, 2001; (2001) 191235898.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. L. Goode, J. L. Stanford, M. A. Peters, M. Janer, M. Gibbs, S. Kolb, M. D. Badzioch, L. Hood, E. A. Ostrander, and G. P. Jarvik
Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci
Clin. Cancer Res., September 1, 2001; 7(9): 2739 - 2749.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Taplin and S.-M. Ho
The Endocrinology of Prostate Cancer
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Giguere, E. Dewailly, J. Brisson, P. Ayotte, N. Laflamme, A. Demers, V.-I. Forest, S. Dodin, J. Robert, and F. Rousseau
Short Polyglutamine Tracts in the Androgen Receptor Are Protective against Breast Cancer in the General Population
Cancer Res., August 1, 2001; 61(15): 5869 - 5874.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. N. Lim, R. M. Nixon, H. Chen, I. A. Hughes, and J. R. Hawkins
Evidence That Longer Androgen Receptor Polyglutamine Repeats Are a Causal Factor for Genital Abnormalities
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3207 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W.-M. Xue, G. A. Coetzee, R. K. Ross, R. Irvine, L. Kolonel, B. E. Henderson, and S. A. Ingles
Genetic Determinants of Serum Prostate-specific Antigen levels in Healthy Men from a Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 575 - 579.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Westberg, F. Baghaei, R. Rosmond, M. Hellstrand, M. Landen, M. Jansson, G. Holm, P. Bjorntorp, and E. Eriksson
Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor {beta} Gene Are Associated with Androgen Levels in Women
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2562 - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Buchanan, N. M. Greenberg, H. I. Scher, J. M. Harris, V. R. Marshall, and W. D. Tilley
Collocation of Androgen Receptor Gene Mutations in Prostate Cancer
Clin. Cancer Res., May 1, 2001; 7(5): 1273 - 1281.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
B. Lin, J. T. White, C. Ferguson, S. Wang, R. Vessella, R. Bumgarner, L. D. True, L. Hood, and P. S. Nelson
Prostate Short-Chain Dehydrogenase Reductase 1 (PSDR1): A New Member of the Short-Chain Steroid Dehydrogenase/Reductase Family Highly Expressed in Normal and Neoplastic Prostate Epithelium
Cancer Res., February 1, 2001; 61(4): 1611 - 1618.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
E. A. Platz, E. B. Rimm, W. C. Willett, P. W. Kantoff, and E. Giovannucci
Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals
J Natl Cancer Inst, December 20, 2000; 92(24): 2009 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Mononen, K. Syrjäkoski, M. Matikainen, T. L. J. Tammela, J. Schleutker, O.-P. Kallioniemi, J. Trapman, and P. A. Koivisto
Two Percent of Finnish Prostate Cancer Patients Have a Germ-line Mutation in the Hormone-binding Domain of the Androgen Receptor Gene
Cancer Res., November 1, 2000; 60(22): 6479 - 6481.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Mifsud, S. Ramirez, and E. L. Yong
Androgen Receptor Gene CAG Trinucleotide Repeats in Anovulatory Infertility and Polycystic Ovaries
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3484 - 3488.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. W. Hsing, Y.-T. Gao, G. Wu, X. Wang, J. Deng, Y.-L. Chen, I. A. Sesterhenn, F. K. Mostofi, J. Benichou, and C. Chang
Polymorphic CAG and GGN Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: A Population-based Case-Control Study in China
Cancer Res., September 1, 2000; 60(18): 5111 - 5116.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
M. C. Bosland
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Mori, T. Ushiyama, K. Inoue, and S. Hukuda
Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis
Rheumatology, May 1, 2000; 39(5): 530 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. M. Lange, H. Chen, K. Brierley, H. Livermore, K. J. Wojno, C. D. Langefeld, K. Lange, and K. A. Cooney
The Polymorphic Exon 1 Androgen Receptor CAG Repeat in Men with a Potential Inherited Predisposition to Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 439 - 442.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
H.N. Lim, H. Chen, S. McBride, A.M. Dunning, R.M. Nixon, I.A. Hughes, and J.R. Hawkins
Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males
Hum. Mol. Genet., March 22, 2000; 9(5): 829 - 834.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. E. Henderson and H. S. Feigelson
Hormonal carcinogenesis
Carcinogenesis, March 1, 2000; 21(3): 427 - 433.
[Abstract] [Full Text] [PDF]